Targeting therapeutic effects: subcellular location matters. Focus on "Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology".

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

3 citing papers in PubMed.

1. N-cadherin coordinates AMP kinase-mediated lung vascular repair.American journal of physiology. Lung cellular and molecular physiology · 2016
   Article
2. Metformin-stimulated AMPK-α1 promotes microvascular repair in acute lung injury.American journal of physiology. Lung cellular and molecular physiology · 2013
   Article
3. Factors controlling vascular permeability: transmitting mechanical signals. Focus on "Mechanical induction of group V phospholipase A₂ causes lung inflammation and acute lung injury".American journal of physiology. Lung cellular and molecular physiology · 2013
   Article

Corrections and comments

• Comment on
  Pharmacological AMP-kinase activators have compartment-specific effects on cell physiology.2011

Authors and funding

1 author.

Funding

Abstract

PubMed holds no abstract for this paper.

Indexed as